$74.01 +1.87 (%) Charles River Laboratories International Inc - New York Stock Exchange, Inc.

Dec. 6, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Mid-Morning Market Update: Markets Open Higher; Time Warner Posts Mixed Q4 Results

    Benzinga | Feb. 10, 2016 | 09:49AM EST
  2. Earnings Scheduled For February 10, 2016

    Benzinga | Feb. 10, 2016 | 04:09AM EST
  3. Carl Announces Company Stock Options

    GuruFocus | Jan. 25, 2016 | 23:04PM EST
  4. Carl Announces Completion of Private Placement

    GuruFocus | Jan. 21, 2016 | 23:05PM EST
  5. Carl Announces Due Diligence for Issue of Up to $2M in Convertible Notes

    GuruFocus | Jan. 5, 2016 | 23:02PM EST
  6. INC Research Holdings Aims For Top Five CRO Status

    IBD | Dec. 28, 2015 | 16:56PM EST
  7. Carl Added to CSE Composite Index

    GuruFocus | Dec. 18, 2015 | 23:08PM EST
  8. Carl Announces Non-Brokered Private Placement

    GuruFocus | Dec. 9, 2015 | 23:06PM EST
  9. Carl Announces New Brand and Name Change

    GuruFocus | Oct. 26, 2015 | 23:03PM EST
  10. Carl Announces Formation of Strategic Advisory Board and Appointment of Lawrie Gaffney; Kevin ...

    GuruFocus | Oct. 21, 2015 | 23:02PM EST
  11. Carl Capital Corp. Completes Acquisition of FlowWorks Inc.

    GuruFocus | Oct. 15, 2015 | 23:03PM EST
  12. Benzinga's Top Upgrades

    Benzinga | Oct. 12, 2015 | 08:09AM EST
  13. Carl Capital Corp. to Acquire FlowWorks Inc.

    GuruFocus | Sep. 28, 2015 | 23:02PM EST
  14. Charles River Laboratories, AstraZeneca Renew Strategic Partnership Agreement

    Benzinga | Jul. 30, 2015 | 06:09AM EST
  15. Benzinga's Top Downgrades

    Benzinga | Jul. 10, 2015 | 08:07AM EST
  16. US Stock Futures Jump Ahead Of Jobless Claims Data

    Benzinga | Jul. 9, 2015 | 06:41AM EST
  17. Carl Appoints Rick Sanderson to the Board of Directors

    GuruFocus | Jun. 30, 2015 | 23:03PM EST
  18. Earnings Scheduled For February 10, 2015

    Benzinga | Feb. 10, 2015 | 04:42AM EST
  19. Top 4 NYSE Stocks In The Medical Laboratories & Research Industry With The Highest ROE

    Benzinga | Nov. 4, 2014 | 05:22AM EST
  20. John Rogers Comments on Charles River Laboratories Intl Inc

    GuruFocus | Jul. 22, 2014 | 16:06PM EST
  21. John Rogers' Ariel Fund Second Quarter 2014 Commentary

    GuruFocus | Jul. 22, 2014 | 15:51PM EST
  22. Charles River Aims To Be 'One-Stop Shop' With Buyout

    IBD | Mar. 13, 2014 | 10:39AM EST
  23. Morgan Stanley Feels Confidence in Charles River Laboratories Following Solid 4Q13 EPS Report

    Benzinga | Feb. 12, 2014 | 09:36AM EST
  24. CHARLES RIVER LABS

    IBD | Feb. 11, 2014 | 18:34PM EST
  25. Earnings Scheduled For February 11, 2014

    Benzinga | Feb. 11, 2014 | 04:34AM EST
  26. Parexel Plunges After 3 CROs Report Earnings

    IBD | Oct. 30, 2013 | 10:41AM EST
  27. Parexel Stock Rises As Analyst Upgrades, Touts CROs

    IBD | Oct. 4, 2013 | 11:25AM EST
  28. Medical Research Firms Tap Drug Development Trend

    IBD | Aug. 30, 2013 | 15:40PM EST
  29. Medical Research Firms Tap Drug Development Trend

    IBD | Aug. 30, 2013 | 15:40PM EST
  30. Earnings Scheduled For February 13, 2013

    Benzinga | Feb. 12, 2013 | 19:13PM EST
  31. Robert Olstein's Largest New Stock Picks

    GuruFocus | Feb. 12, 2013 | 08:48AM EST
  32. UPDATE: Sterne Agee Reiterates Buy Rating, Raises PT on Charles River Laboratories

    Benzinga | Jan. 14, 2013 | 07:10AM EST
  33. Weekly CFO Sells HIGHLIGHT: TMO, BLOX, VRSK, CRL, INGR, GWRE

    GuruFocus | Jan. 13, 2013 | 11:44AM EST
  34. Charles River Laboratories International Inc (CRL) Corp. ...

    GuruFocus | Jan. 8, 2013 | 06:34AM EST
  35. Charles River Labs Closes Purchase of Majority Ownership of Vital River

    Benzinga | Jan. 7, 2013 | 10:00AM EST
  36. UPDATE: JP Morgan Upgrades Charles River Laboratories to Overweight on Risk/Reward

    Benzinga | Dec. 13, 2012 | 05:06AM EST
  37. Mid-Afternoon Market Update: Bernanke Press Conference Leads to Drop in the Markets

    Benzinga | Dec. 12, 2012 | 08:56AM EST
  38. Mid-Day Market Update: Fed to Continue Stimulus, Markets Rise

    Benzinga | Dec. 12, 2012 | 07:26AM EST
  39. UPDATE: ISI Group Cuts PT to $39 on Charles River Laboratories Following Negative Guidance

    Benzinga | Dec. 12, 2012 | 06:41AM EST
  40. Top 4 NYSE Stocks In The Biotechnology Industry With The Highest ROA

    Benzinga | Dec. 6, 2012 | 20:44PM EST
  41. Charles River Laboratories International Reports Operating Results (10-Q)

    GuruFocus | Nov. 1, 2012 | 05:02AM EST
  42. UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on Charles River Laboratories

    Benzinga | Oct. 31, 2012 | 05:06AM EST
  43. Top 4 NYSE Stocks In The Biotechnology Industry With The Highest Revenue Estimates

    Benzinga | Oct. 23, 2012 | 20:27PM EST
  44. Charles River Laboratories International (CRL) Chairman, President and CEO James C Foster sells ...

    GuruFocus | Oct. 3, 2012 | 10:00AM EST
  45. Charles River Laboratories International (CRL) Chairman, President and CEO James C Foster sells ...

    GuruFocus | Oct. 3, 2012 | 10:00AM EST
  46. Charles River Laboratories International (CRL) Corp. ...

    GuruFocus | Oct. 3, 2012 | 08:00AM EST
  47. Charles River Opens New Biomedical Diagnostic Facility

    Benzinga | Sep. 6, 2012 | 01:41AM EST
  48. Charles River Acquires Accugenix

    Benzinga | Aug. 29, 2012 | 07:00AM EST
  49. Charles River Laboratories International Reports Operating Results (10-Q)

    GuruFocus | Aug. 7, 2012 | 13:28PM EST
  50. Charles River Laboratories International (CRL) Corp. ...

    GuruFocus | Jul. 12, 2012 | 09:10AM EST
Trading Center